Exploring Recent Developments in Lilly's Obesity Treatment and U.K. Trials
Recent discussions highlight advancements in obesity medications and the effectiveness of clinical trials in the U.K.
Editorial Staff Apr 28
Health
Latest Health stories from Life.
Exploring AI Challenges in Healthcare: Insights from Google's Clinical Director
A recent discussion with Google's clinical director sheds light on the significant challenges facing AI applications in healthcare, including updates on Doctronic's Utah experiment.
Editorial Staff Apr 28
Concerns Mount Over Trump's Drug Pricing Policy and Purdue Pharma's Legal Troubles
Industry leaders express significant worries regarding the implications of Trump's drug pricing plan, while Purdue Pharma's sentencing underscores persistent challenges in the pharmaceutical sector.
Editorial Staff Apr 28
Navigating the AI Revolution in Health Care
As the AI revolution unfolds, its implications for patients, clinicians, and health care leaders are becoming increasingly significant. Experts weigh in on the potential impacts.
Editorial Staff Apr 28
The Oversight in Brain Health Discussions: Ignoring Mental Illness
Experts argue that neglecting mental illness in conversations about brain health limits our understanding and potential for improvement in this critical area.
Editorial Staff Apr 28
Overview of Mental Health and Substance Use Policies Under Trump Administration
A new KFF tracker reveals significant federal policy actions related to mental health and substance use during President Trump’s second term.
Editorial Staff Apr 27
Concerns Grow Over New U.S. Hepatitis B Vaccine Policy for Newborns
A recent recommendation to limit hepatitis B vaccinations at birth to only those infants deemed at risk raises alarms about potential increases in infections among newborns.
Editorial Staff Apr 27
Tracking Abortion Policies in the U.S. Post-Roe v. Wade
A new research initiative is monitoring changes in state abortion laws and related legal actions since the Supreme Court's decision to overturn Roe v. Wade.
Editorial Staff Apr 27
Erasca's Experimental Cancer Drug Shows Encouraging Early Trial Results
Erasca has reported that its experimental treatment for pancreatic and lung cancers has delivered results that exceed initial expectations in early trials.
Editorial Staff Apr 27
Trends in State Abortion Coverage Policies: A 2025 Perspective
An interactive map illustrates the rise in states implementing laws that limit abortion coverage in Medicaid and private insurance since 2010, highlighting significant policy shifts.
Editorial Staff Apr 27
Democrats Express Frustration Over RFK Jr.'s Lack of Transparency
Robert F. Kennedy Jr. has reportedly failed to provide answers to Democrats' inquiries, particularly regarding a controversial contract, leading to increased frustrations.
Editorial Staff Apr 27
Trump Administration Issues Warning on Federal Funding for Fentanyl Test Strips
The Trump administration has expressed concerns regarding the use of federal funds for fentanyl test strips, indicating a shift away from harm reduction strategies.
Editorial Staff Apr 27
Insights from Archelle Georgiou on Prior Authorization Goals
Archelle Georgiou, a former insider at a major health insurer, discusses the objectives behind prior authorization processes in healthcare.
Editorial Staff Apr 27
Analysis of FY 2027 NSRP Appropriations Bill Highlights Global Health Funding
The House Appropriations Committee has released the FY 2027 National Security, Department of State and Related Programs Appropriations Bill, focusing on global health funding.
Editorial Staff Apr 27
Astellas Resumes XLMTM Gene Therapy Trials Following Previous Fatalities
Astellas is moving forward with its XLMTM gene therapy trials despite earlier reports of deaths. Meanwhile, Veradermics celebrates success in its hair loss pill trial, and the FDA accelerates reviews for psychedelics.
Editorial Staff Apr 27
Intellia's Gene Editing Treatment Shows Significant Promise for Hereditary Angioedema
Recent trial results indicate that a single dose of Intellia's CRISPR treatment can significantly reduce swelling attacks in patients with hereditary angioedema, raising interest in one-time therapies.
Editorial Staff Apr 27
Examining the Potential Risks of GLP-1 Medications on Eating Disorders
As GLP-1 medications become more common for weight management, concerns about their effects on eating behaviors are emerging. Ongoing research aims to clarify these risks.
Editorial Staff Apr 27
Veradermics Achieves Success with Hair Loss Treatment in Late-Stage Trials
Veradermics has reported positive results from its late-stage trial for a new hair loss drug, positioning itself as a leading contender in a rapidly growing market.
Editorial Staff Apr 27
Motif Neurotech's Innovative Approach to Depression Treatment Gains FDA Approval
Motif Neurotech has received FDA approval to commence an initial feasibility trial for a brain implant aimed at treating depression, marking a significant step in neurotechnology.
Editorial Staff Apr 27
Study Reveals NIH-Funded Research Often Overlooks Sex Differences
A recent study indicates that less than 50% of NIH-funded research papers include analysis or reporting of data by sex, highlighting a significant gap in research practices.
Editorial Staff Apr 27